Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses

Passive immunization using monoclonal antibodies will play a vital role in the fight against COVID-19. The recent emergence of viral variants with reduced sensitivity to some current antibodies and vaccines highlights the importance of broad cross-reactivity.

@media (min-width:1042px){ #menu-primary-nav .sub-menu{ transition:transform 233ms 610ms, opacity 89ms calc(233ms + 610ms - 89ms) linear; } } @media (max-width:1041px){ #primary-navigation .menu-primary-nav-container{ -webkit-transition: -webkit-transform .233s ease-out, opacity .233s linear; transition: transform .233s ease-out, opacity .233s linear; } }